CONCORD DRUGS
Back to Balance Sheet
|
CONCORD DRUGS Last 5 Year Short Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Short Term Provisions | ₹0.21 Cr | ₹0.32 Cr | ₹0.48 Cr | ₹0.67 Cr |
What is the latest Short Term Provisions ratio of CONCORD DRUGS ?
| Year | Short Term Provisions |
|---|---|
| Mar2025 | ₹0.21 Cr |
| Mar2024 | ₹0.32 Cr |
| Mar2023 | ₹0.48 Cr |
| Mar2022 | ₹0.67 Cr |
How is Short Term Provisions of CONCORD DRUGS Trending?
| Years | Short Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.21 Cr | -35.22 | |
| Mar2024 | ₹0.32 Cr | -33.19 | |
| Mar2023 | ₹0.48 Cr | -29.06 | |
| Mar2022 | ₹0.67 Cr | - | |
Compare Short Term Provisions of peers of CONCORD DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD DRUGS | ₹92.7 Cr | 8.9% | -2.8% | 33.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,946.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,907.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,674.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,648.7 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
CONCORD DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD DRUGS | 8.9% |
-2.8% |
33.7% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses